Identifying the cells of origins of brain tumors using somatic mutations

The CBTTC has unique access to and a network for obtaining post-mortem samples that are vital for this work. This is because we are most interested in normal brain tissue adjacent to brain tumors, which is usually not preserved or stored.
Additionally, the CBTTC has already sequenced many pediatric brain tumors, which could be immediately used as raw data for our analyses. Comprehensive genomic sequencing of these tumor types is not available anywhere else.